Regístrese
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
ISSN: 1665-2681

ANNALS OF HEPATOLOGY is an international open access journal published bimonthly and is funded by Medica Sur Clinical Foundation, Mexico City, Mexico. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin-American Association for the Study of the Liver (ALEH) and the Canadian Association for the Study of the Liver (CASL) and publishes original papers, concise reviews, letters to the Editor, invited editorials, opinions and viewpoints in the field of Hepatology.

ANNALS OF HEPATOLOGY'S main topics are alcoholic liver disease, viral hepatitis (HAV, HBV, HCV, HDV, HEV), NAFLD/NASH, genetic liver diseases, autoimmune hepatitis, drug¿induced liver injury and biliary diseases. The journal's aim is to publish articles focused on basic, clinic care and translational research that seeks to prevent rather than treat the complications of endstage liver disease.

See more Open Access

Indexed in:

Scopus, Web of Science, Medline

See more

Follow us:

1.895 (2018)
Impact Factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.

© Clarivate Analytics, Journal Citation Reports 2017 2018

Impact Factor 2018
1.895
CiteScore 2018

NOTICE Undefined index: citeScoreUrl (includes_ws_v2/modulos/cuerpo/info-revista-informacion.php[62])
CiteScore measures average citations received per document published. Read more

CiteScore 2018
1.55

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR
0.628

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP
0.638
See more
Hide
Issue
Vol. 18. Issue 4.
Pages 537-654 (July - August 2019)
Editorial
Genome-based nutritional strategies to prevent chronic liver disease
Sonia Roman
Ann Hepatol.2019;18:537-8
Open access
Opinions
Hepatitis E and chronic liver damage in apparently immunocompetent individuals: Now what?
Santiago Mirazo, Juan Arbiza
Ann Hepatol.2019;18:539-40
Open access
Viewpoints
Hepatitis E in Latin America
Rosa Elena Sarmiento-Silva, Francisco Arenas-Huertero
Ann Hepatol.2019;18:541-2
Open access
Concise reviews
Current concepts in acute liver failure
Maximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol.2019;18:543-52
Open access
Liver disease in pregnancy: Medical aspects and their implications for mother and child
Carmen Selene García-Romero, Carolina Guzman, Alicia Cervantes, Marco Cerbón
Ann Hepatol.2019;18:553-62
Open access
Original articles
Non-alcoholic fatty liver disease and neurological defects
Rita Moretti, Paola Caruso, Silvia Gazzin
Ann Hepatol.2019;18:563-70
Open access
First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in Mexico
Oliver Viera-Segura, Mauricio Realpe-Quintero, Arturo Panduro, Sonia Roman, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Jorge L. Trujillo-Ochoa, Nora A. Fierro
Ann Hepatol.2019;18:571-7
Open access
Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population
Shira Zelber-Sagi, Reut Zur, Tamar Thurm, Alex Goldstein, Ofir Ben-Assuli, Gabriel Chodick, Oren Shibolet
Ann Hepatol.2019;18:578-84
Open access
Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?
Filiz Akyüz, Bilger Çavuş, Binnur Pınarbaşı, Mürvet Bozacı, Bülent Baran, Umit Akyuz, Ahmet Uyanıkoglu, Kadir Demir, Fatih Beşışık, Sadakat Özdil, Güngör Boztaş, Zeynel Mungan, Selim Badur, Sadi Yenen, Sabahattin Kaymakoglu
Ann Hepatol.2019;18:585-9
Open access
Establishment of competitive binding assay to detect and differentiate hepatitis E virus infection
Jiyue Wen, Weizhuo Lu, Jihong Meng
Ann Hepatol.2019;18:590-4
Open access
Endoscopic retrograde cholangiopancreatography versus surgery for choledocholithiasis – A meta-analysis
Fernando C. Schacher, Sofia M. Giongo, Fernanda J.P. Teixeira, Ângelo Z. Mattos
Ann Hepatol.2019;18:595-600
Open access
Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients
Alisha Ahmed, Christopher Schriever, Nicholas Britt, Jenna Yager, Ronish Amin, Liam McGuey, Nimish Patel
Ann Hepatol.2019;18:601-6
Open access
Niemann-Pick disease A or B in four pediatric patients and SMPD1 mutation carrier frequency in the Mexican population
Magdalena Cerón-Rodríguez, Edgar Ricardo Vázquez-Martínez, Constanza García-Delgado, Alberto Ortega-Vázquez, Pedro Valencia-Mayoral, Lyuva Ramírez-Devars, Christian Arias-Villegas, Irma Eloísa Monroy-Muñoz, Marisol López, Alicia Cervantes, Marco Cerbón, Verónica Fabiola Morán-Barroso
Ann Hepatol.2019;18:613-9
Open access
Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
Marcela M. De Luna-Saldivar, Iván A. Marino-Martinez, Moisés A. Franco-Molina, Lydia G. Rivera-Morales, Gabriela Alarcón-Galván, Paula Cordero-Pérez, Augusto Rojas-Martínez, Cristina Rodríguez-Padilla, Linda E. Muñoz-Espinosa
Ann Hepatol.2019;18:620-6
Open access
The relationship between coagulation disorders and the risk of bleeding in cirrhotic patients
Asma Labidi, Héla Baccouche, Monia Fekih, Sonia Mahjoub, Nadia BenMustapha, Meriem Serghini, Neila BenRomdhane, Jalel Boubaker
Ann Hepatol.2019;18:627-32
Open access
Folic acid ameliorates homocysteine-induced angiogenesis and portosystemic collaterals in cirrhotic rats
Hsin-Ling Ho, Ming-Hung Tsai, Yu-Hsin Hsieh, Teh-Ia Huo, Ching-Chih Chang, Fa-Yauh Lee, Hui-Chun Huang, Ming-Chih Hou, Shou-Dong Lee
Ann Hepatol.2019;18:633-9
Open access
Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients
Seyed Y. Hosseini, Neda Sanaei, Mohamad-Reza Fattahi, Seyed A. Malek-Hosseini, Jamal Sarvari
Ann Hepatol.2019;18:640-5
Open access
Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency
Alejandra Consuelo-Sánchez, Rodrigo Vázquez-Frias, Alejandra Reyes-De La Rosa, Carlos P. Acosta-Rodríguez-Bueno, María P. Ortal-Vite, Jorge J. Cebolla
Ann Hepatol.2019;18:646-50
Open access
Case report
Occult central pontine myelinolysis post liver transplant: A consequence of pre-transplant hyponatremia
Julie Zhu, Fatema Al-Alkim, Trana Hussaini, Alexandra Vertinsky, Danielle Byrne, Siegfried R. Erb, A. Jon Stoessl, Eric M. Yoshida
Ann Hepatol.2019;18:651-4
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.